Takeda Pharmaceutical Company Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Takeda Pharmaceutical Company Limited's balance sheet done over the years? Its assets were worth $15,108,792,000,000 last year, which is more than in the previous period. 52% of Takeda Pharmaceutical Company Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $7,834,787,000,000, which means an increase by 3% compared compared to last year.
Debt to Assets
| 2015 | 4296192000000 | 2.09T | 48.65% |
|---|---|---|---|
| 2016 | 3824085000000 | 1.81T | 47.41% |
| 2017 | 4355782000000 | 2.40T | 55.26% |
| 2018 | 4106463000000 | 2.08T | 50.87% |
| 2019 | 13872322000000 | 8.70T | 62.78% |
| 2020 | 12821094000000 | 8.09T | 63.13% |
| 2021 | 12912293000000 | 7.73T | 59.91% |
| 2022 | 13178018000000 | 7.49T | 56.87% |
| 2023 | 13957750000000 | 7.60T | 54.47% |
| 2024 | 15108792000000 | 7.83T | 51.86% |
TAK Balance Sheet (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 457.8B | 533.53B | 849.69B | 966.22B | 637.61B | 702.09B | 294.52B | 319.45B | 451.42B | 652.14B |
Short term investments | 15.08B | 20.17B | 25.30B | 36.59B | 15.82B | 23.27B | 80.64B | 56.68B | 108.6B | 61.27B |
Net receivables | 612.43B | 681.69B | 724.37B | 812.71B | 784.92B | 749.11B | 428.79B | 356.45B | 430.57B | 466.82B |
Inventory | 1.20T | 986.45B | 853.16B | 753.88B | 759.59B | 986.74B | 212.94B | 226.29B | 254.01B | 262.35B |
Other current assets | 263.38B | 196.27B | 141.09B | 122.78B | 114.19B | 109.66B | 57.91B | 301.77B | 64.14B | 77.46B |
Total current assets | 2.55T | 2.39T | 2.59T | 2.71T | 2.46T | 3.05T | 1.07T | 1.26T | 1.37T | 1.52T |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 1.98T | 1.69T | 1.58T | 1.45T | 1.38T | 1.31T | 536.80B | 530.15B | 551.91B | 526.16B |
Goodwill | 5.41T | 4.79T | 4.40T | 4.03T | 4.01T | 4.16T | 1.02T | 1.02T | 779.31B | 821.91B |
Intangible assets | 4.27T | 4.26T | 3.81T | 3.90T | 4.17T | 4.86T | 1.01T | 1.06T | 743.12B | 939.38B |
Long term investments | 89.83B | 378.85B | 330.13B | 348.35B | 369.45B | 306.89B | 304.38B | 303.04B | 159.56B | 251.74B |
Other non-current assets | 785.85B | 63.32B | 82.61B | 100.34B | 103.84B | 87.47B | 77.97B | 54.40B | 45.60B | 82.41B |
Total non-current assets | 12.55T | 11.55T | 10.58T | 10.19T | 10.35T | 10.82T | 3.02T | 3.09T | 2.45T | 2.77T |
Total assets | 15.10T | 13.95T | 13.17T | 12.91T | 12.82T | 13.87T | 4.10T | 4.35T | 3.82T | 4.29T |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 616.48B | 587.98B | 119.48B | 200.47B | 206.38B | 158.47B | 459.65B |
Short term debt | 433.45B | 399.22B | 203.99B | 22.15B | 586.81B | 984.94B | 18M | 545.02B | 228.46B | 103.25B |
Total current liabilities | 2.31T | 2.48T | 2.14T | 1.77T | 2.17T | 2.51T | 737.50B | 1.36T | 857.21B | 1.01T |
| Non-current liabilities: | ||||||||||
Long term debt | 5.02T | 4.46T | 4.14T | 4.61T | 4.50T | 4.76T | 985.64B | 656.56B | 539.76B | 645.57B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 491.75B | 658.67B | 755.83B | 574.57B | 451.92B | 310.96B | 159.52B | 267.67B | 173.15B | 288.85B |
Total non-current liabilities | 5.52T | 5.12T | 5.34T | 5.96T | 5.91T | 6.19T | 1.35T | 1.04T | 955.66B | 1.07T |
Total liabilities | 7.83T | 7.60T | 7.49T | 7.73T | 8.09T | 8.70T | 2.08T | 2.40T | 1.81T | 2.09T |
| Data source | Data source | Data source | Data source | Data source | Data source |